• Regeneration

    November 16-18, 2017, Milan Italy

    Read more ...  
  • IBRO-UM5

     

    Advanced School on Neuroimmunology and Brain Infections

    Rabat, Morocco | November 21 - December 4, 2017

    Read more ...  
  • Postdoctoral Research Fellow in Australia

    Apply for a position as a Postdoctoral Research Fellow at the University of Queensland in Brisbane, Australia. 

    Read more ...  
  • AAT-AD/PD 2018

    15 - 18 March in Turin, Italy

    Read more ...  
  • CUBANNI 2017 - report

    CUBANNI 2017

    Read more ...  
  • ESOC 2018 - 4th European Stroke Organisation Conference

    ESOC 2018
    The 4th European STroke Organisation Conference

    16 - 18 May, 2018
    Gothenburg, Sweden

    Read more ...  

 


Professor of Neurology
the Karolinska Institutet

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

 

 

Tomas Olsson is professor of Neurology at the Karolinska Institutet, Stockholm Sweden.

He is active in a large number of academic groups and societies in the neurology area. He is member of the board of the Swedish MS society, has been chairman for the previous Swedish expert committee for MS and is co-founder of the European School of Neuroimmunology (ESNI). He is also a member of the International MS societies, former president of the international Society of Neuroimmunology (ISNI) and former member executive board of the European Committee for the Treatment of Multiple Sclerosis (ECTRIMS). He is also a member of the Nobel assembly.

He has been co-author of over 470 original papers, and many of them published in high impact journals like Nature Genetics, Cell, Lancet, the Journal of Experimental Medicine, the Journal of Clinical investigation and the Journal of Neuroscience.

Current research interest is in the immunology, epidemiology and genetics of multiple sclerosis and its experimental models, as well as neuro-infections.

Joomla Template by Joomla51.com

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie policy